Contact Center Solutions Industry News

TMCNet:  Pfizer (PFE) Crosses Pivot Point Resistance at $25.16

[December 03, 2012]

Pfizer (PFE) Crosses Pivot Point Resistance at $25.16

Dec 03, 2012 (SmarTrend(R) News Watch via COMTEX) -- Shares of Pfizer (NYSE:PFE) have bullishly opened above the pivot of $24.94 today and have reached the first resistance level of $25.16. Analysts will be watching for a cross of the next upside pivot targets of $25.30 and $25.66.

Pfizer (NYSE:PFE) has potential upside of 9.3% based on a current price of $25.25 and analysts' consensus price target of $27.61. The stock should discover initial support at its 50-day moving average (MA) of $24.73 and subsequent support at its 200-day MA of $22.97.

Pfizer share prices have moved between a 52-week high of $26.09 and a 52-week low of $18.77 and are now trading 35% above that low price at $25.25 per share. Over the past week, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.2%.

SmarTrend is tracking the current trend status for Pfizer and will alert subscribers who have PFE in their portfolio or watchlist when shares have changed trend direction.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Contact Center Solutions's Homepage ]

Subscribe here for your FREE Contact
Center Solutions
enewslettter.

Events

Weekly Live Demo
Contact Center Solutions

Register Today!


Weekly Live Demo
CaaS Small Center

Register Today!